#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Dermatitis atopic Dementia Alzheimer's type Asthma Type 2 diabetes mellitus Breast cancer metastatic Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Necrotising myositis Hereditary haemorrhagic telangiectasia Candida infection Penile squamous cell carcinoma Activated PI3 kinase delta syndrome Juvenile idiopathic arthritis Hypersomnia Muscular dystrophy Transitional cell carcinoma Arrhythmogenic right ventricular dysplasia Rhabdomyosarcoma recurrent Vascular calcification Breast angiosarcoma Cytokine release syndrome Rhabdomyosarcoma More trials…

    Learn about Rare Diseases

    Acquired haemophilia – Treatment X-linked lymphoproliferative syndrome – Treatment Angiosarcoma metastatic – Life with Disease Mucopolysaccharidosis – Treatment Nephrotic syndrome – Basic Information Pituitary-dependent Cushing’s syndrome – Diagnostics Haemophilia A with anti factor VIII – Diagnostics Hereditary hypophosphataemic rickets – Trials in Disease Mast cell activation syndrome – Trials in Disease KBG syndrome – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Azd8421 Tildrakizumab Flupentixol Decanoate Specific Nucleic Acid Sna-Xfsa Bulevirtide Verapamil Db-Oto-5 Tetracaine Hydrochloride Sodium Chloride Ph. Eur. HALOBETASOL PROPIONATE Linerixibat Abemaciclib OMTX705 Alendronic Acid Nandrolone Decanoate Apraglutide Glofitamab Selumetinib HYDROGEN VERCIRNON More therapies…

    Learn about Your Condition

    Laryngeal cancer stage III Merycism Acute HIV infection Pancreatic carcinoma Soft tissue sarcoma Thrombectomy Vertebrobasilar stroke Mitral valve incompetence Endometrial cancer metastatic Femoral neck fracture Dyskinesia Acquired haemophilia Procedural headache Coma Testis cancer More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Centre Hospitalier Departemental Vendee

Centre Hospitalier Departemental Vendee

Boulevard Stephane Moreau, La Roche sur Yon, 85925, France

Want to learn more about this study or check if you can participate? Contact us.

  • Study on the Effectiveness of Obefazimod for Patients with Moderate to Severe Ulcerative Colitis

    Not yet recruiting

    3 1
    Investigated Diseases:
    • Colitis ulcerative
    Investigated Drugs:
    • Obefazimod
    Belgium France Germany Italy Poland Spain

  • Study on the Effectiveness of Obefazimod for Patients with Moderate to Severe Ulcerative Colitis

    Not yet recruiting

    3 1
    Investigated Diseases:
    • Colitis ulcerative
    Investigated Drugs:
    • Obefazimod
    Belgium France Germany Italy Poland Spain

  • Study on CAL02 and Sodium Chloride for Patients with Severe Community-Acquired Bacterial Pneumonia

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Pneumonia
    Investigated Drugs:
    • Cholesterol
    • Sodium Chloride
    • Sphingomyelin (Egg)
    Belgium Czechia France Greece Hungary Latvia +3

  • Study of Baricitinib for Treating Hospital-Acquired Pneumonia in Critically Ill Patients with a Proinflammatory Profile

    Not yet recruiting

    4 1 1 1
    Investigated Diseases:
    • Pneumonia
    Investigated Drugs:
    • Baricitinib
    Belgium France The Netherlands Spain

  • Gedatolisib plus drug combination for HR‑positive, HER2‑negative advanced breast cancer patients whose disease progressed after CDK4/6 inhibitor therapy

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Hormone receptor positive HER2 negative breast cancer
    • Hormone receptor positive breast cancer
    Investigated Drugs:
    • Alpelisib
    • Dexamethasone
    • Fulvestrant
    Austria Belgium Bulgaria Czechia France Germany +6

  • A Study of Mevrometostat and Enzalutamide for Men with Metastatic Castration-Sensitive Prostate Cancer Who Have Not Received Hormonal Therapy or Chemotherapy

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Hormone-dependent prostate cancer
    • Prostate cancer metastatic
    Investigated Drugs:
    • 5,8-Dichloro-2-[(4-Methoxy-6-Methyl-2-Oxo-1,2-Dihydropyridin-3-Yl)Methyl]-7-[(R)-Methoxy(Oxetan-3-Yl)Methyl]-3,4-Dihydroisoquinolin-1(2H)-One
    • Enzalutamide
    Belgium Bulgaria Czechia Finland France Germany +6

  • Study of inhaled interferon beta-1a (SNG001) for treatment of patients with viral lower respiratory tract infections who require mechanical ventilation

    Not recruiting

    2 1
    Investigated Drugs:
    • Interferon Beta-1A
    Belgium France The Netherlands Spain

  • Study on COVID-19 Prevention Using Sipavibart and Cilgavimab for Patients with Weakened Immune Systems

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Cilgavimab
    • SIPAVIBART
    • Sodium Chloride
    Belgium Denmark France Germany Poland Spain

  • Study on the Effectiveness and Safety of Brensocatib for Patients with Chronic Rhinosinusitis Without Nasal Polyps

    Not recruiting

    2 1 1
    Investigated Drugs:
    • BRENSOCATIB
    Belgium Bulgaria Czechia Denmark France Germany +5

  • Study of REGN7544 for Treating Adults with Low Blood Pressure Caused by Sepsis

    Not recruiting

    2 1
    Investigated Diseases:
    • Hypotension
    • Sepsis
    Investigated Drugs:
    • REGN7544
    France
Previous Page
1 … 10 11 12 13 14 … 21
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!